You can view the current or previous issues of Diabetes Health online, in their entirety, anytime you want.
Click Here To View
See if you qualify for our free healthcare professional magazines. Click here to start your application for Pre-Diabetes Health, Diabetes Health Pharmacist and Diabetes Health Professional.
Latest Medications Research Articles
Popular Medications Research Articles
Highly Recommended Medications Research Articles
Send a link to this page to your friends and colleagues.
Fenofibrate, a drug designed to lower blood fat levels, helps reduce amputation risk.
Patients with type 2 diabetes reduced their risk of having a foot amputated by 36 percent when they took fenofibrate, a drug designed to lower blood fat levels.
An Australian research team at the National Health and Medical Research Council Clinical Trials Centre at the University of Sydney tracked 9,795 type 2s, ages 50 to 75, over a five-year period. Half took 200 mg of fenofibrate daily, while the other half took a placebo.
At the end of the study, the risk of a first amputation among patients taking fenofibrate was 36 percent lower than among those taking the placebo. Researchers also noted that fenofibrate takers had a 47 percent lower risk of amputations below the ankle of feet that did not have large-vessel disease.
(Large vessel disease is caused by atherosclerosis of large arteries, usually the result of cardiovascular disease, as opposed to the microvascular disease commonly found in people with type 2.)
The beneficial aspects of fenofibrate consumption seemed to emerge after 1.5 years of continuous use. However, despite the notably encouraging reduction in the risk for below-the-ankle amputations, taking fenofibrate produced no reduction in the risk for above-the-ankle amputations.
Categories: Amputations & Amputee, Diabetes, Diabetes, Foot Care, Health, Health Care, Medications, Medications Research, Type 2 Issues
Diabetes Health is the essential resource for people living with diabetes- both newly diagnosed and experienced as well as the professionals who care for them. We provide balanced expert news and information on living healthfully with diabetes. Each issue includes cutting-edge editorial coverage of new products, research, treatment options, and meaningful lifestyle issues.

Comments
Add your comments about this article below. You can add comments as a registered user or anonymously. If you choose to post anonymously your comments will be sent to our moderator for approval before they appear on this page. If you choose to post as a registered user your comments will appear instantly.
When voicing your views via the comment feature, please respect the Diabetes Health community by refraining from comments that could be considered offensive to other people. Diabetes Health reserves the right to remove comments when necessary to maintain the cordial voice of the diabetes community.
For your privacy and protection, we ask that you do not include personal details such as address or telephone number in any comments posted.
Don't have your Diabetes Health Username? Register now and add your comments to all our content.
Register...
Register your Diabetes Health Username here.
Have Your Say...